These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3293684)

  • 1. Antagonism of N-methylaspartate and synaptic responses of neurones in the rat ventrobasal thalamus by ketamine and MK-801.
    Salt TE; Wilson DG; Prasad SK
    Br J Pharmacol; 1988 Jun; 94(2):443-8. PubMed ID: 3293684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in results from in vivo and in vitro studies on the use-dependency of N-methylaspartate antagonism by MK-801 and other phencyclidine receptor ligands.
    Davies SN; Martin D; Millar JD; Aram JA; Church J; Lodge D
    Eur J Pharmacol; 1988 Jan; 145(2):141-51. PubMed ID: 2832187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of action and pharmacological specificity of the anticonvulsant NMDA antagonist MK-801: a voltage clamp study on neuronal cells in culture.
    Halliwell RF; Peters JA; Lambert JJ
    Br J Pharmacol; 1989 Feb; 96(2):480-94. PubMed ID: 2647206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The competitive N-methyl-D-aspartate (NMDA) antagonist CGS 19755 attenuates the rate-decreasing effects of NMDA in rhesus monkeys without producing ketamine-like discriminative stimulus effects.
    France CP; Woods JH; Ornstein P
    Eur J Pharmacol; 1989 Jan; 159(2):133-9. PubMed ID: 2651134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.
    Wong EH; Kemp JA; Priestley T; Knight AR; Woodruff GN; Iversen LL
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):7104-8. PubMed ID: 3529096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
    Koek W; Woods JH; Winger GD
    J Pharmacol Exp Ther; 1988 Jun; 245(3):969-74. PubMed ID: 2838610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of N-methylaspartate receptors in mediating responses of rat and cat spinal neurones to defined sensory stimuli.
    Headley PM; Parsons CG; West DC
    J Physiol; 1987 Apr; 385():169-88. PubMed ID: 2821241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of synaptic versus non-synaptic epileptogenesis by NMDA antagonists in the in vitro hippocampus.
    Ashton D; Willems R; De Prins E; Wauquier A
    Epilepsy Res; 1988; 2(3):219-22. PubMed ID: 2848699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MK-801 powerfully protects against N-methyl aspartate neurotoxicity.
    Olney J; Price M; Salles KS; Labruyere J; Frierdich G
    Eur J Pharmacol; 1987 Sep; 141(3):357-61. PubMed ID: 3311770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine and MK-801 prevent degeneration of thalamic neurons induced by focal cortical seizures.
    Clifford DB; Zorumski CF; Olney JW
    Exp Neurol; 1989 Sep; 105(3):272-9. PubMed ID: 2670599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The possible participation of N-methyl-D-aspartate receptors in the stimulating action on respiration of thyroliberin and its analog RGH 2202].
    Chizh BA; Kasparov SA
    Farmakol Toksikol; 1990; 53(1):35-6. PubMed ID: 2158462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NMDA antagonist, MK-801, suppresses long-term potentiation, kindling, and kindling-induced potentiation in the perforant path of the unanesthetized rat.
    Gilbert ME; Mack CM
    Brain Res; 1990 Jun; 519(1-2):89-96. PubMed ID: 2204470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The noncompetitive N-methyl-D-aspartate antagonists, MK-801, phencyclidine and ketamine, increase the potency of general anesthetics.
    Daniell LC
    Pharmacol Biochem Behav; 1990 May; 36(1):111-5. PubMed ID: 2190239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward.
    Herberg LJ; Rose IC
    Psychopharmacology (Berl); 1989; 99(1):87-90. PubMed ID: 2550989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic administration of MK-801 prevents N-methyl-D-aspartate-induced neuronal degeneration in rat brain.
    Foster AC; Gill R; Kemp JA; Woodruff GN
    Neurosci Lett; 1987 May; 76(3):307-11. PubMed ID: 3295603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excitatory amino acid receptors and synaptic transmission in the rat ventrobasal thalamus.
    Salt TE
    J Physiol; 1987 Oct; 391():499-510. PubMed ID: 2895178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-methyl-D-aspartate (NMDA) receptors control respiratory off-switch in cat.
    Foutz AS; Champagnat J; Denavit-Saubié M
    Neurosci Lett; 1988 May; 87(3):221-6. PubMed ID: 2837690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dextromethorphan inhibits NMDA-induced convulsions.
    Ferkany JW; Borosky SA; Clissold DB; Pontecorvo MJ
    Eur J Pharmacol; 1988 Jun; 151(1):151-4. PubMed ID: 3046955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacological selectivity of three NMDA antagonists.
    Childs AM; Evans RH; Watkins JC
    Eur J Pharmacol; 1988 Jan; 145(1):81-6. PubMed ID: 2894999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate.
    Anis NA; Berry SC; Burton NR; Lodge D
    Br J Pharmacol; 1983 Jun; 79(2):565-75. PubMed ID: 6317114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.